Comprehensive Pain Management of the Fox Valley, Appleton, WI, USA.
Neuromodulation. 2010 Oct;13(4):288-90; discussion 291. doi: 10.1111/j.1525-1403.2010.00276.x.
Our goal was to determine the efficacy of spinal cord stimulation for patients with intractable post-herniorrhaphy pain which conventional treatment failed to ameliorate.
The patients underwent an uneventful spinal cord stimulator (SCS) trial with percutaneous placement of two eight-electrode epidural leads (Medtronic Inc, Minneapolis, MN, USA) to level T7-T8-T9.
Upon experiencing excellent pain relief over the next two days during the trial, the patients were implanted with permanent leads and rechargeable or non-rechargeable generators two to four weeks later and reported sustained pain relief during following 12 months after implantation.
We conclude that SCS offers an alternative treatment option for intractable post-herniorrhaphy pain. This type of treatment should be considered for use in a select group of patients when all conventional treatments failed.
我们的目的是确定脊髓刺激治疗难治性疝修补术后疼痛的疗效,这些患者经常规治疗未能改善。
患者行脊髓刺激器(SCS)试验,经皮放置两个 8 电极硬膜外导(美国明尼苏达州明尼阿波利斯市美敦力公司)至 T7-T8-T9 水平。
在试验期间的接下来两天经历了极好的疼痛缓解后,患者在两到四周后植入了永久性导和可充电或不可充电的发生器,并在植入后的 12 个月内报告持续的疼痛缓解。
我们得出结论,SCS 为难治性疝修补术后疼痛提供了另一种治疗选择。当所有常规治疗均失败时,应考虑将这种治疗方法用于选择的患者群体。